A Drastic Reduction in the Life Span of Cystatin C L68Q Carriers Due to Life-Style Changes during the Last Two Centuries

English version České info

Hereditary cystatin C amyloid angiopathy (HCCAA) is an autosomal dominant disease with high penetrance, manifest by brain hemorrhages in young normotensive adults. In Iceland, this condition is caused by the L68Q mutation in the cystatin C gene, with contemporary carriers reaching an average age of only 30 years. Here, we report, based both on linkage disequilibrium and genealogical evidence, that all known copies of this mutation derive from a common ancestor born roughly 18 generations ago. Intriguingly, the genealogies reveal that obligate L68Q carriers born 1825 to 1900 experienced a drastic reduction in life span, from 65 years to the present-day average. At the same time, a parent-of-origin effect emerged, whereby maternal inheritance of the mutation was associated with a 9 year reduction in life span relative to paternal inheritance. As these trends can be observed in several different extended families, many generations after the mutational event, it seems likely that some environmental factor is responsible, perhaps linked to radical changes in the life-style of Icelanders during this period. A mutation with such radically different phenotypic effects in reaction to normal variation in human life-style not only opens the possibility of preventive strategies for HCCAA, but it may also provide novel insights into the complex relationship between genotype and environment in human disease.

Vyšlo v časopise: A Drastic Reduction in the Life Span of Cystatin C L68Q Carriers Due to Life-Style Changes during the Last Two Centuries. PLoS Genet 4(6): e32767. doi:10.1371/journal.pgen.1000099
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1000099

Souhrn

Zdroje

1. BarnhamKJCappaiRBeyreutherKMastersCLHillAF 2006 Delineating common molecular mechanisms in Alzheimer's and prion diseases. Trends Biochem Sci 31 465 472

2. YamadaM 2004 Cerebral amyloid angiopathy and gene polymorphisms. J Neurol Sci 226 41 44

3. ArnasonA 1935 Apoplexie und ihre vererbung. Acta Psychiat Neruol Suppl VII

4. GrubbAO 2000 Cystatin C–properties and use as diagnostic marker. Adv Clin Chem 35 63 99

5. PalsdottirAAbrahamsonMThorsteinssonLArnasonAOlafssonI 1988 Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet 2 603 604

6. AbrahamsonMJonsdottirSOlafssonIJenssonOGrubbA 1992 Hereditary cystatin C amyloid angiopathy: identification of the disease-causing mutation and specific diagnosis by polymerase chain reaction based analysis. Hum Genet 89 377 380

7. LofbergHGrubbAONilssonEKJenssonOGudmundssonG 1987 Immunohistochemical characterization of the amyloid deposits and quantitation of pertinent cerebrospinal fluid proteins in hereditary cerebral hemorrhage with amyloidosis. Stroke 18 431 440

8. GudmundssonGHallgrimssonJJonassonTABjarnasonO 1972 Hereditary cerebral haemorrhage with amyloidosis. Brain 95 387 404

9. LevyESastreMKumarAGalloGPiccardoP 2001 Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients. J Neuropathol Exp Neurol 60 94 104

10. KaeserSAHerzigMCCoomaraswamyJKilgerESelenicaML 2007 Cystatin C modulates cerebral beta-amyloidosis. Nat Genet 39 1437 1439

11. MiWPawlikMSastreMJungSSRadvinskyDS 2007 Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models. Nat Genet 39 1440 1442

12. BertramLMcQueenMBMullinKBlackerDTanziRE 2007 Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39 17 23

13. HelgasonAYngvadottirBHrafnkelssonBGulcherJStefanssonK 2005 An Icelandic example of the impact of population structure on association studies. Nat Genet 37 90 95

14. SveinbjornsdottirSBlondalHGudmundssonGKjartanssonOJonsdottirS 1996 Progressive dementia and leucoencephalopathy as the initial presentation of late onset hereditary cystatin-C amyloidosis. Clinicopathological presentation of two cases. J Neurol Sci 140 101 108

15. MorganHDSutherlandHGMartinDIWhitelawE 1999 Epigenetic inheritance at the agouti locus in the mouse. Nat Genet 23 314 318

16. WolffGLKodellRLMooreSRCooneyCA 1998 Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. Faseb J 12 949 957

17. WaterlandRAJirtleRL 2003 Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23 5293 5300

18. ScriverCR 2007 The PAH gene, phenylketonuria, and a paradigm shift. Hum Mutat 28 831 845

19. DruggeUAnderssonRChizariFDanielssonMHolmgrenG 1993 Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis. J Med Genet 30 388 392

20. JenssonOGudmundssonGArnasonABlondalHPetursdottirI 1987 Hereditary cystatin C (gamma-trace) amyloid angiopathy of the CNS causing cerebral hemorrhage. Acta Neurol Scand 76 102 114

21. FjalldalJBenediktssonKSigurdssonJEllingsenL 2001 Automated genotyping: combining neural networks and decision trees to perform robust allele calling.

22. PalssonBPalssonFPerlinMGudbjartssonHStefanssonK 1999 Using quality measures to facilitate allele calling in high-throughput genotyping. Genome Res 9 1002 1012

23. ExcoffierLSlatkinM 1995 Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12 921 927

24. SlatkinMRannalaB 2000 Estimating allele age. Annu Rev Genomics Hum Genet 1 225 249

25. LabudaMLabudaDKorab-LaskowskaMColeDEZietkiewiczE 1996 Linkage disequilibrium analysis in young populations: pseudo-vitamin D-deficiency rickets and the founder effect in French Canadians. Am J Hum Genet 59 633 643

26. JonssonGMagnussonM 1997 Hagskinna: Icelandic historical statistics Reykjavik Statistics Iceland

27. 2005 A haplotype map of the human genome. Nature 437 1299 1320

28. ReeveJPRannalaB 2002 DMLE+: Bayesian linkage disequilibrium gene mapping. Bioinformatics 18 894 895

29. JonssonG 1998 Changes in Food Consumption in Iceland 1770–1940. Scandinavian Economic History Review XLVI 24 41